This 6-month feeding trial will assess the effects of a new fresh diet on the digestive health and fecal microbiome of healthy dogs. Fecal samples will be collected from 16 dogs at baseline and at months 1, 3, and 6. Analysis will be conducted to investigate the benefits observed.
AnimalBiome Partnership Studies
Pioneering partnership studies on microbiome health to improve pet wellness
Industry partners →
Academic partners →
Non-profit partners →
Have questions about AnimalBiome partnerships?
Industry Partners
Improve the efficacy of your products through an AnimalBiome study
Sample industry studies
Raw food feeding trial & dog gut microbiome
EpiCor study for cats and dogs with itchy skin
This study determined the most effective dosage of EpiCor to provide symptom relief and microbiome benefits for cats and dogs with itchy skin and other skin problems. EpiCor is an immune modulating postbiotic ingredient derived from yeast.
Cricket protein and the dog gut microbiome with Jiminy’s
This study was conducted with Jiminy’s to investigate the effects of edible cricket on the gut microbiome of healthy dogs. Crickets contain protein and prebiotic fiber and their inclusion in the diet supports a healthy level of bacterial diversity.
Petcurean GO! Solutions Digestion + Gut Health diet study
This study tested the effect of a new diet designed for digestion and gut health on the microbiome and stooling habits of healthy dogs. We saw significant improvements in stool quality and support for a healthy microbiome, particularly during the challenge of diet transitions.
Interested in a partnership study with AnimalBiome?
Academic Partners
Access the world’s largest database for pet microbiome data to support your research
Oral FMT & Parvovirus enteritis in dogs
Dr. Jethro Forbes, Cornell University
Dr. Jethro Forbes, a professor at the Cornell University College of Veterinary Medicine is conducting a placebo-controlled study to investigate whether fecal microbiota transplants (FMT) can reduce hospitalization duration and clinical outcomes in dogs with parvovirus. Dogs admitted to the veterinary hospital will receive the FMT or placebo capsules in addition to standard care.
Oral FMT & Canine cognitive dysfunction in dogs
Dr. Curtis Dewey, Cornell University
Dr. Curtis Dewey, a veterinary neurologist at the Cornell University College of Veterinary Medicine is conducting a study to investigate whether fecal microbiota transplants (FMT) can lessen cognitive decline and improve cognition in dogs diagnosed with canine cognitive dysfunction – the canine analog of human Alzheimer disease (AD). Dogs enrolled will take FMT capsules for 90 days.
Oral FMT & Diabetes Mellitus in cats and dogs
Dr. Arnon Gal, University of Illinois
Dr. Arnon Gal, a professor of small-animal internal medicine at the University of Illinois, College of Veterinary Medicine is conducting a placebo-controlled study to find out whether changing the population of microbes in the gut using FMT in an oral capsule can improve glucose tolerance in diabetic dogs and cats and potentially even cure diabetes in cats.
Non-Profit Partners
Use microbiome science research to help pets live longer, healthier lives
Sample non-profit studies
Preventing diarrhea in a service dog breeding program with FMT
Diarrhea can be a serious problem for puppies in service dog breeding programs, and may prevent them from completing training. In the study, we aim to prevent or reduce this by treating the mothers with FMT prior to pregnancy, so that they can pass on a healthier microbiome to their puppies. We also tested the efficacy of GMP for treating diarrhea in puppies. This study is a partnership with Leader Dogs for the Blind.
Changes in the gut microbiome of Golden Retrievers with cancer
In partnership with the Morris Animal Foundation and Hills Pet Nutrition, we are using samples from the Golden Retriever Lifetime Study to compare the gut microbiomes of Golden Retrievers that passed away from cancer (lymphoma or hemangiosarcoma) to those that are healthy. We hope to understand changes that may occur in the microbiome around the time that cancer develops, and as it progresses.